ROR1 and neuroblastoma: Moreover, the combination of oncolytic virus and anti-ROR1-CAR-NK cells significantly increased the survival of NSG mice bearing human neuroblastoma xenografts, demonstrating the effectiveness of this combination in vivo [189].